News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

I-SPY COVID Trial: An Adaptive Platform Trial to Reduce Mortaility and Ventilator Requirements for Critically Ill Patients

Study Status:

Open for enrollment

Contact Information:

(956) 362-2396

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. The approach that we will take in this trial is to focus on finding agents with a big impact on reducing both mortality and time on ventilators for those critically ill as a result of COVID 19. Both of these endpoints are critical to managing the health crisis created by the global pandemic.

Information: 

Principal Investigator
Praveen Vijhani, MD
Co-PI
Luis Cantu Jr.
Sponsor
National Center for Advancing Translation Sciences
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram